Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial
10.1016/j.ygyno.2017.02.039
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Elsevier BV
2023
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239625 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-239625 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2396252023-08-29T21:43:17Z Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial Wysham, Weiya Z Schaffer, Elisabeth M Coles, Theresa Roque, Dario R Wheeler, Stephanie B Kim, Kenneth H DUKE-NUS MEDICAL SCHOOL Cost-effectiveness Bevacizumab Aurelia 10.1016/j.ygyno.2017.02.039 Gynecologic Oncology 145 2 340-345 2023-05-22T06:34:42Z 2023-05-22T06:34:42Z 2017-05 2023-05-19T07:57:31Z Article Wysham, Weiya Z, Schaffer, Elisabeth M, Coles, Theresa, Roque, Dario R, Wheeler, Stephanie B, Kim, Kenneth H (2017-05). Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial. Gynecologic Oncology 145 (2) : 340-345. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ygyno.2017.02.039 0090-8258 https://scholarbank.nus.edu.sg/handle/10635/239625 Elsevier BV Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Cost-effectiveness Bevacizumab Aurelia |
| spellingShingle |
Cost-effectiveness Bevacizumab Aurelia Wysham, Weiya Z Schaffer, Elisabeth M Coles, Theresa Roque, Dario R Wheeler, Stephanie B Kim, Kenneth H Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial |
| description |
10.1016/j.ygyno.2017.02.039 |
| author2 |
DUKE-NUS MEDICAL SCHOOL |
| author_facet |
DUKE-NUS MEDICAL SCHOOL Wysham, Weiya Z Schaffer, Elisabeth M Coles, Theresa Roque, Dario R Wheeler, Stephanie B Kim, Kenneth H |
| format |
Article |
| author |
Wysham, Weiya Z Schaffer, Elisabeth M Coles, Theresa Roque, Dario R Wheeler, Stephanie B Kim, Kenneth H |
| author_sort |
Wysham, Weiya Z |
| title |
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial |
| title_short |
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial |
| title_full |
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial |
| title_fullStr |
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial |
| title_full_unstemmed |
Adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost effectiveness analysis of the AURELIA trial |
| title_sort |
adding bevacizumab to single agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: a cost effectiveness analysis of the aurelia trial |
| publisher |
Elsevier BV |
| publishDate |
2023 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/239625 |
| _version_ |
1779155726592114688 |